Literature DB >> 10995222

Detailed structural analysis of glycosidase/inhibitor interactions: complexes of Cex from Cellulomonas fimi with xylobiose-derived aza-sugars.

V Notenboom1, S J Williams, R Hoos, S G Withers, D R Rose.   

Abstract

Detailed insights into the mode of binding of a series of tight-binding aza-sugar glycosidase inhibitors of two fundamentally different classes are described through X-ray crystallographic studies of complexes with the retaining family 10 xylanase Cex from Cellulomonas fimi. Complexes with xylobiose-derived aza-sugar inhibitors of the substituted "amidine" class (xylobio-imidazole, K(i) = 150 nM; xylobio-lactam oxime, K(i) = 370 nM) reveal lateral interaction of the "glycosidic" nitrogen with the acid/base catalyst (Glu127) and hydrogen bonding of the sugar 2-hydroxyl with the catalytic nucleophile (Glu233), as expected. Tight binding of xylobio-isofagomine (K(i) = 130 nM) appears to be a consequence of strong interactions of the ring nitrogen with the catalytic nucleophile while, surprisingly, no direct protein contacts are made with the ring nitrogen of the xylobio-deoxynojirimycin analogue (K(i) = 5800 nM). Instead the nitrogen interacts with two ordered water molecules, thereby accounting for its relatively weaker binding, though it still binds some 1200-fold more tightly than does xylobiose, presumably as a consequence of electrostatic interactions at the active site. Dramatically weaker binding of these same inhibitors to the family 11 xylanase Bcx from Bacillus circulans (K(i) from 0.5 to 1.5 mM) is rationalized for the substituted amidines on the basis that this enzyme utilizes a syn protonation trajectory and likely hydrolyzes via a (2,5)B boat transition state. Weaker binding of the deoxynojirimycin and isofagomine analogues likely reflects the energetic penalty for distortion of these analogues to a (2,5)B conformation, possibly coupled with destabilizing interactions with Tyr69, a conserved, catalytically essential active site residue.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995222     DOI: 10.1021/bi0010625

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Solution and gas-phase H/D exchange of protein-small-molecule complexes: Cex and its inhibitors.

Authors:  Yang Kang; Peran Terrier; Chuanfan Ding; D J Douglas
Journal:  J Am Soc Mass Spectrom       Date:  2011-10-18       Impact factor: 3.109

2.  Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.

Authors:  Brian L Mark; Don J Mahuran; Maia M Cherney; Dalian Zhao; Spencer Knapp; Michael N G James
Journal:  J Mol Biol       Date:  2003-04-11       Impact factor: 5.469

3.  Gas phase noncovalent protein complexes that retain solution binding properties: Binding of xylobiose inhibitors to the beta-1, 4 exoglucanase from cellulomonas fimi.

Authors:  Milica Tesić; Jacqueline Wicki; David K Y Poon; Stephen G Withers; Donald J Douglas
Journal:  J Am Soc Mass Spectrom       Date:  2006-09-26       Impact factor: 3.109

4.  Crystal structure and snapshots along the reaction pathway of a family 51 alpha-L-arabinofuranosidase.

Authors:  Klaus Hövel; Dalia Shallom; Karsten Niefind; Valery Belakhov; Gil Shoham; Timor Baasov; Yuval Shoham; Dietmar Schomburg
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

5.  The complete conformational free energy landscape of β-xylose reveals a two-fold catalytic itinerary for β-xylanases.

Authors:  Javier Iglesias-Fernández; Lluís Raich; Albert Ardèvol; Carme Rovira
Journal:  Chem Sci       Date:  2014-10-27       Impact factor: 9.825

6.  Thermodynamic Analysis for Binding of 4-O-β-tri-N-acetylchitotriosyl Moranoline, a Transition State Analogue Inhibitor for Hen Egg White Lysozyme.

Authors:  Makoto Ogata; Tamo Fukamizo; Takayuki Ohnuma
Journal:  Front Mol Biosci       Date:  2021-06-10

7.  Gluco-1 H-imidazole: A New Class of Azole-Type β-Glucosidase Inhibitor.

Authors:  Sybrin P Schröder; Liang Wu; Marta Artola; Thomas Hansen; Wendy A Offen; Maria J Ferraz; Kah-Yee Li; Johannes M F G Aerts; Gijsbert A van der Marel; Jeroen D C Codée; Gideon J Davies; Herman S Overkleeft
Journal:  J Am Chem Soc       Date:  2018-04-04       Impact factor: 15.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.